BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32608920)

  • 1. [Pharmacogenetics in daily practice].
    van Gelder T; van Schaik RHN
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32608920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models.
    Hayward J; McDermott J; Qureshi N; Newman W
    Pharmacogenomics; 2021 Aug; 22(12):761-776. PubMed ID: 34467776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
    Bank PCD; Swen JJ; Guchelaar HJ
    BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Black box" pharmacogenetic decision-support tools in psychiatry.
    Bousman CA; Eyre HA
    Braz J Psychiatry; 2020 Apr; 42(2):113-115. PubMed ID: 31994639
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection.
    Bousman CA; Zierhut H; Müller DJ
    Clin Pharmacol Ther; 2019 Aug; 106(2):309-312. PubMed ID: 31004441
    [No Abstract]   [Full Text] [Related]  

  • 7. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenetic associations and evidence-based pharmacogenomics guidelines: supporting label and off-label use of drug-gene interaction data.
    Kisor DF; Monte AA; Müller DJ
    Pharmacogenomics; 2020 May; 21(7):427-430. PubMed ID: 32319356
    [No Abstract]   [Full Text] [Related]  

  • 9. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
    Roden DM; Van Driest SL; Mosley JD; Wells QS; Robinson JR; Denny JC; Peterson JF
    Clin Pharmacol Ther; 2018 May; 103(5):787-794. PubMed ID: 29377064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
    Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics-Based Patient Care Program in a Real-World Setting.
    Kim RB
    Clin Pharmacol Ther; 2019 Nov; 106(5):933-935. PubMed ID: 31520405
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
    Amstutz U; Henricks LM; Offer SM; Barbarino J; Schellens JHM; Swen JJ; Klein TE; McLeod HL; Caudle KE; Diasio RB; Schwab M
    Clin Pharmacol Ther; 2018 Feb; 103(2):210-216. PubMed ID: 29152729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
    Petit C; Croisetière A; Chen F; Laverdière I
    Pharmacogenomics; 2020 Mar; 21(4):247-256. PubMed ID: 32180495
    [No Abstract]   [Full Text] [Related]  

  • 16. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.
    Cavallari LH; Van Driest SL; Prows CA; Bishop JR; Limdi NA; Pratt VM; Ramsey LB; Smith DM; Tuteja S; Duong BQ; Hicks JK; Lee JC; Obeng AO; Beitelshees AL; Bell GC; Blake K; Crona DJ; Dressler L; Gregg RA; Hines LJ; Scott SA; Shelton RC; Weitzel KW; Johnson JA; Peterson JF; Empey PE; Skaar TC;
    Genet Med; 2019 Oct; 21(10):2255-2263. PubMed ID: 30894703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of pharmacogenetics in clinical practice: problems and solutions.
    Baskys A
    J Neural Transm (Vienna); 2019 Jan; 126(1):109-113. PubMed ID: 29922908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Rapid Pharmacogenomic Testing Assay in a Mobile Molecular Biology Laboratory (2MoBiL).
    Psarias G; Iliopoulou E; Liopetas I; Tsironi A; Spanos D; Tsikrika A; Kalafatis K; Tarousi D; Varitis G; Koromina M; Siamoglou S; Patrinos GP
    OMICS; 2020 Nov; 24(11):660-666. PubMed ID: 33064577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
    O'Donnell PH; Wadhwa N; Danahey K; Borden BA; Lee SM; Hall JP; Klammer C; Hussain S; Siegler M; Sorrentino MJ; Davis AM; Sacro YA; Nanda R; Polonsky TS; Koyner JL; Burnet DL; Lipstreuer K; Rubin DT; Mulcahy C; Strek ME; Harper W; Cifu AS; Polite B; Patrick-Miller L; Yeo KT; Leung E; Volchenboum SL; Altman RB; Olopade OI; Stadler WM; Meltzer DO; Ratain MJ
    Clin Pharmacol Ther; 2017 Nov; 102(5):859-869. PubMed ID: 28398598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.